RxDoctor Payments DataLook up a doctor →

Steven Bromley, MD

Neurology · Audubon, NJNPI 1962591586

Payments from drug & device makers

$1,690,662in general payments, 2019–2025

Across 3,559 payments — averaging $475.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • EMD Serono, Inc.$192K
  • E.r. Squibb & Sons, L.L.C.$163K
  • Novartis$163K
  • AbbVie$160K
  • Bristol Myers Squibb$124K
  • AstraZeneca$119K
  • plus $770K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
EMD Serono, Inc.399$191,710
E.r. Squibb & Sons, L.L.C.127$162,717
Novartis76$162,717
AbbVie(2 entities)487$160,075
Bristol Myers Squibb251$124,236
AstraZeneca(2 entities)123$118,531
Otsuka America Pharmaceutical, Inc.112$109,715
Lundbeck LLC196$100,908
Biogen209$94,364
Genentech USA, Inc.121$84,236
Lilly USA, LLC90$69,373
UCB, Inc.167$65,143
Sanofi79$55,559
TG Therapeutics, Inc.37$42,913
Amgen(2 entities)62$32,188
Avanir Pharmaceuticals, Inc.62$26,352
Biohaven Pharmaceuticals, Inc.44$26,305
Eisai Inc.54$16,208
Argenx US, Inc.33$16,065
Biohaven Pharmaceutical Holding Company Ltd.39$9,531
ANI Pharmaceuticals, Inc.58$7,691
Pfizer105$4,555
Teva Pharmaceuticals USA, Inc.47$743
Amneal Pharmaceuticals LLC39$575
Neurocrine Biosciences, Inc.31$490
Acadia Pharmaceuticals Inc45$439
Mallinckrodt Hospital Products Inc.27$418
MDD US Operations, LLC21$417
Axsome Therapeutics, Inc.33$413
Impel Pharmaceuticals Inc.22$375
Johnson & Johnson(2 entities)23$349
Takeda Pharmaceuticals U.S.A., Inc.22$328
Kyowa Kirin, Inc.22$323
Scilex Pharmaceuticals Inc.27$318
Harmony Biosciences LLC16$272
Jazz Pharmaceuticals Inc.18$267
Averitas Pharma Inc.14$214
Sunovion Pharmaceuticals Inc.12$211
Merz Pharmaceuticals, LLC9$196
Upsher-smith Laboratories LLC12$180
Supernus Pharmaceuticals, Inc.13$177
Boston Scientific7$176
SK Life Science, Inc.10$168
GE HealthCare9$157
Neuronetics, Inc.4$152
Arbor Pharmaceuticals, Inc.8$136
Vanda Pharmaceuticals Inc.8$122
Impel Pharmaceuticals LLC6$117
GRT US Holding, Inc.12$117
Neurelis, Inc.9$116
Currax Pharmaceuticals LLC8$114
Merz North America, Inc.4$109
CSL Behring6$108
Abbott4$89
Acorda Therapeutics, Inc6$88
Philips North America LLC6$87
Adlon Therapeutics L.p.6$81
Merck6$77
Life Molecular Imaging Ltd5$68
Almatica Pharma LLC5$67

How this compares

$1,690,662 in reported general payments places this provider in the 95th percentile of 521 neurology providers in New Jersey.

See all neurology providers in New Jersey

Medicare billing

Part B allowed, 2024
$4,025,254
Medicare patients
500
Services billed
115,614

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Audubon

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →